Google+ Facebook Twitter Twitter

IBMS responds to Dame Sally's report

The IBMS has issued a response to Professor Dame Sally Davies’ annual report, which calls on the government to develop genomic medicine’s role in the NHS.

Sarah May, IBMS Deputy Chief Executive, commented on Dame Sally’s focus on genomic testing.

“We support the Chief Medical Officer’s view that DNA testing should become standard across cancer care,” she said. 

“The UK has a workforce of highly skilled and trained biomedical scientists that are preparing to meet this new diagnostic and treatment challenge.” 

She added that the IBMS is launching two new molecular pathology qualifications in 2017. 

These are “intended to directly support the new and expanding science and technology and help to achieve Dame Sally’s vision for personalised diagnosis and healthcare”.

Related Articles

Growing brains

Growing brains

They may only be small collections of cells at present, but neurological surgeon Ben Waldau believes that brain organoids could have a big impact in the future.

100,000 Genomes Project hits halfway

100,000 Genomes Project hits halfway

Genomics England has passed the halfway point in its mission to sequence 100,000 genomes.

The genetic basis of Alzheimer's

After he was awarded another illustrious prize for his Alzheimer’s disease research, we speak to Professor John Hardy about his work.

Molecular printing advance

A new fabrication technology could allow researchers to recreate complex biological environments.